Personal information

Pediatric Hematology, Platelet
United States

Activities

Employment (2)

The Johns Hopkins University, School of Medicine: Baltimore, Maryland, US

2023-11-01 to present | Assistant Professor of Pediatric Hematology (Department of Pediatrics)
Employment
Source: Self-asserted source
Matthew Merguerian

The Johns Hopkins University, School of Medicine: Baltimore, Maryland, US

2021-01-01 to 2023-10-31 | Instructor of Pediatric Hematology (Department of Pediatrics)
Employment
Source: Self-asserted source
Matthew Merguerian

Education and qualifications (5)

Johns Hopkins University: Baltimore, MD, US

2017-07 to 2020-12 | Fellow (Pediatric Hematology/Oncology)
Qualification
Source: Self-asserted source
Matthew Merguerian

National Cancer Institute: Bethesda, MD, US

2017 to 2020 | Fellow (Pediatric Oncology)
Qualification
Source: Self-asserted source
Matthew Merguerian

Yale University School of Medicine: New Haven, CT, US

2014 to 2017 | Resident (Pediatrics)
Qualification
Source: Self-asserted source
Matthew Merguerian

Columbia University College of Physicians and Surgeons: New York, NY, US

2006 to 2014 | MD, PhD
Education
Source: Self-asserted source
Matthew Merguerian

University of Chicago: Chicago, IL, US

2002 to 2006 | B.A. in Chemistry and Biology
Education
Source: Self-asserted source
Matthew Merguerian

Professional activities (2)

American Academy of Pediatrics: Chicago, Illinois, US

2017 to present | Fellow
Membership
Source: Self-asserted source
Matthew Merguerian

The New York Academy of Sciences: New York, NY, US

2010 to 2012 | Trainee
Membership
Source: Self-asserted source
Matthew Merguerian

Funding (2)

Johns Hopkins T32: Lab Training in Pediatric Hematology/Oncology.

2018 to 2020 | Award
National Cancer Institute (Md., Md., US)
Part of GRANT_NUMBER:

2T32CA060441

Source: Self-asserted source
Matthew Merguerian

Columbia University T32: NIH NIGMS Medical Scientist Training Program.

2008 to 2011 | Award
National Institute of General Medical Sciences (Md., Md., US)
Part of GRANT_NUMBER:

5T32GM007367

Source: Self-asserted source
Matthew Merguerian

Works (13)

Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in RUNX1–familial platelet disorder

Science Translational Medicine
2025 | Journal article
EID:

2-s2.0-85215065649

Part of ISSN: 19466242 19466234
Contributors: Mohammadhosseini, M.; Enright, T.; Duvall, A.; Chitsazan, A.; Lin, H.-Y.; Ors, A.; Davis, B.A.; Nikolova, O.; Bresciani, E.; Diemer, J. et al.
Source: Self-asserted source
Matthew Merguerian via Scopus - Elsevier

Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy

Blood Advances
2024 | Journal article
EID:

2-s2.0-85182995321

Part of ISSN: 24739537 24739529
Contributors: Yu, K.; Deuitch, N.; Merguerian, M.; Cunningham, L.; Davis, J.; Bresciani, E.; Diemer, J.; Andrews, E.; Young, A.; Donovan, F. et al.
Source: Self-asserted source
Matthew Merguerian via Scopus - Elsevier
grade
Preferred source (of 2)‎

Genomic Landscape of Patients with Germline RUNX1 Variants and Familial Platelet Disorder with Myeloid Malignancy

bioRxiv
2023 | Other
EID:

2-s2.0-85150990854

Part of ISSN: 26928205
Contributors: Yu, K.; Deuitch, N.; Merguerian, M.; Cunningham, L.; Davis, J.; Bresciani, E.; Diemer, J.; Andrews, E.; Young, A.; Donovan, F. et al.
Source: Self-asserted source
Matthew Merguerian via Scopus - Elsevier

Natural history study of patients with familial platelet disorder with associated myeloid malignancy

Blood
2023 | Journal article
EID:

2-s2.0-85175345434

Part of ISSN: 15280020 00064971
Contributors: Cunningham, L.; Merguerian, M.; Calvo, K.R.; Davis, J.; Deuitch, N.T.; Dulau-Florea, A.; Patel, N.; Yu, K.; Sacco, K.; Bhattacharya, S. et al.
Source: Self-asserted source
Matthew Merguerian via Scopus - Elsevier
grade
Preferred source (of 2)‎

Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma

Cold Spring Harbor Molecular Case Studies
2021 | Journal article
EID:

2-s2.0-85112763346

Part of ISSN: 23732873
Contributors: Liu, T.; Merguerian, M.D.; Rowe, S.P.; Pratilas, C.A.; Chen, A.R.; Ladle, B.H.
Source: Self-asserted source
Matthew Merguerian via Scopus - Elsevier
grade
Preferred source (of 2)‎

Fr139 GASTROINTESTINAL DISEASE IN PATIENTS WITH FAMILIAL PLATELET DISORDER WITH ASSOCIATED MYELOID MALIGNANCY

Gastroenterology
2021-05 | Journal issue or edition
Part of ISSN: 0016-5085
Source: Self-asserted source
Matthew Merguerian

Germline RUNX1 Deficiency Predisposes to Allergy and Autoimmunity

Journal of Allergy and Clinical Immunology
2021-02 | Journal issue or edition
Part of ISSN: 0091-6749
Source: Self-asserted source
Matthew Merguerian

Definitions and Classification of Hemolytic Anemias

Nelson Textbook of Pediatrics, 21st Ed.
2020 | Book chapter
Source: Self-asserted source
Matthew Merguerian

Hereditary Elliptocytosis, Hereditary Pyropoikilocytosis, and Related Disorders

Nelson Textbook of Pediatrics, 21st Ed.
2020 | Book chapter
Source: Self-asserted source
Matthew Merguerian

Hereditary Spherocytosis

Nelson Textbook of Pediatrics, 21st Ed.
2020 | Book chapter
Source: Self-asserted source
Matthew Merguerian

Hereditary Stomatocytosis

Nelson Textbook of Pediatrics, 21st Ed.
2020 | Book chapter
Source: Self-asserted source
Matthew Merguerian

Paroxysmal Nocturnal Hemoglobinuria and Acanthocytosis

Nelson Textbook of Pediatrics, 21st Ed.
2020 | Book chapter
Source: Self-asserted source
Matthew Merguerian

Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain

Chemistry and Biology
2004 | Journal article
EID:

2-s2.0-3042633729

Part of ISSN: 10745521
Contributors: Karatan, E.; Merguerian, M.; Han, Z.; Scholle, M.D.; Koide, S.; Kay, B.K.
Source: Self-asserted source
Matthew Merguerian via Scopus - Elsevier
grade
Preferred source (of 2)‎

Peer review (2 reviews for 1 publication/grant)

Review activity for The Journal of pediatrics. (2)